| Dr Ajit C Mirani, MD | |
|
231 Weaver St, Unit F, Fall River, MA 02720-1338 | |
| (508) 679-1400 | |
| (508) 679-1449 |
| Full Name | Dr Ajit C Mirani |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 35 Years |
| Location | 231 Weaver St, Fall River, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841263332 | NPI | - | NPPES |
| 2043157 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 219787 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Rehabilitation Associates, P.c. | 2163419375 | 3 |
News Archive
Researchers at Radboud University Medical Center in the Netherlands reported an increase of heparanase activity and heparan sulfate levels in the plasma of patients with coronavirus disease (COVID-19), which was also associated with the severity of the condition – suggesting, in turn, potential treatment utility of low molecular weight heparins. The paper is currently available on the medRxiv* preprint server.
A record of medicine utilization patterns assembled by an interdisciplinary team of researchers at the University of California, Irvine and the UC San Diego School of Medicine reveals the thought, care and scientific rigor clinicians at UC Health medical centers applied in their treatment of patients with COVID-19 in 2020.
DPS Health, a leader in digital behavior change interventions for emergent-risk populations, announced today the launch of its health self-management solution. Designed for health plans, providers systems and employers that are setting population health strategies for the emergent-risk population – adults with one or more pre-chronic or early-stage chronic conditions – the solution includes multi-channel consumer engagement to educate and enroll populations, Virtual Lifestyle ManagementTM to help individuals embrace healthy lifestyles, and a suite of condition-based, self-management programs to help the same individuals manage the impact of one or more conditions.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated the progress of its drug development programs and reported financial results for the three and six months ended June 30, 2010.
The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON (degarelix) as an option for treating advanced hormone-dependent prostate cancer, only in adults with spinal metastases who present with signs or symptoms of spinal cord compression.
› Verified 9 days ago
| Entity Name | Southeast Rehabilitation Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760564413 PECOS PAC ID: 2163419375 Enrollment ID: O20040429000304 |
News Archive
Researchers at Radboud University Medical Center in the Netherlands reported an increase of heparanase activity and heparan sulfate levels in the plasma of patients with coronavirus disease (COVID-19), which was also associated with the severity of the condition – suggesting, in turn, potential treatment utility of low molecular weight heparins. The paper is currently available on the medRxiv* preprint server.
A record of medicine utilization patterns assembled by an interdisciplinary team of researchers at the University of California, Irvine and the UC San Diego School of Medicine reveals the thought, care and scientific rigor clinicians at UC Health medical centers applied in their treatment of patients with COVID-19 in 2020.
DPS Health, a leader in digital behavior change interventions for emergent-risk populations, announced today the launch of its health self-management solution. Designed for health plans, providers systems and employers that are setting population health strategies for the emergent-risk population – adults with one or more pre-chronic or early-stage chronic conditions – the solution includes multi-channel consumer engagement to educate and enroll populations, Virtual Lifestyle ManagementTM to help individuals embrace healthy lifestyles, and a suite of condition-based, self-management programs to help the same individuals manage the impact of one or more conditions.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated the progress of its drug development programs and reported financial results for the three and six months ended June 30, 2010.
The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON (degarelix) as an option for treating advanced hormone-dependent prostate cancer, only in adults with spinal metastases who present with signs or symptoms of spinal cord compression.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ajit C Mirani, MD 231 Weaver St, Unit F, Fall River, MA 02720-1338 Ph: (508) 679-1400 | Dr Ajit C Mirani, MD 231 Weaver St, Unit F, Fall River, MA 02720-1338 Ph: (508) 679-1400 |
News Archive
Researchers at Radboud University Medical Center in the Netherlands reported an increase of heparanase activity and heparan sulfate levels in the plasma of patients with coronavirus disease (COVID-19), which was also associated with the severity of the condition – suggesting, in turn, potential treatment utility of low molecular weight heparins. The paper is currently available on the medRxiv* preprint server.
A record of medicine utilization patterns assembled by an interdisciplinary team of researchers at the University of California, Irvine and the UC San Diego School of Medicine reveals the thought, care and scientific rigor clinicians at UC Health medical centers applied in their treatment of patients with COVID-19 in 2020.
DPS Health, a leader in digital behavior change interventions for emergent-risk populations, announced today the launch of its health self-management solution. Designed for health plans, providers systems and employers that are setting population health strategies for the emergent-risk population – adults with one or more pre-chronic or early-stage chronic conditions – the solution includes multi-channel consumer engagement to educate and enroll populations, Virtual Lifestyle ManagementTM to help individuals embrace healthy lifestyles, and a suite of condition-based, self-management programs to help the same individuals manage the impact of one or more conditions.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated the progress of its drug development programs and reported financial results for the three and six months ended June 30, 2010.
The National Institute for Health and Care Excellence (NICE) today issued its Final Appraisal Determination (FAD) recommending FIRMAGON (degarelix) as an option for treating advanced hormone-dependent prostate cancer, only in adults with spinal metastases who present with signs or symptoms of spinal cord compression.
› Verified 9 days ago
Dr. Douglas R. Johnson, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 231 Weaver St, Unit F, Fall River, MA 02720 Phone: 508-679-1400 Fax: 508-679-1449 | |
Madhavi S.v. Prasad, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 851 Middle St Ste 3300, Fall River, MA 02721 Phone: 774-613-1444 | |
Dr. John A. Magnotta, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-7643 Fax: 508-973-7650 | |
Dr. Parakrama M. Ananta, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 231 Weaver St, Unit F, Fall River, MA 02720 Phone: 508-679-1400 Fax: 508-679-1449 | |
Dr. Andrew Mazur, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 231 Weaver St, Unit F, Fall River, MA 02720 Phone: 508-679-1400 Fax: 508-679-1449 |